Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
The findings of this study support the routine use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve kidney outcomes ...
Researchers compared the incidence of infection-related outcomes and hypoglycemia across antidiabetic drug classes in patients with inflammatory arthritis and diabetes.
Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...
CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association’s Sessions 2025 in New ...
MedPage Today on MSN
GI Risks Similar Among GLP-1 Drugs, but Higher Than With SGLT-2 Inhibitors
T hree popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type ...
An expert discusses the critical need for a holistic, multidisciplinary approach to prevent and manage interconnected ...
HealthDay on MSN
American College of Chest Physicians, Oct. 19-22
The annual meeting of the American College of Chest Physicians was held this year from Oct. 19 to 22 in Chicago, hosting ...
In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...
bHarrington Heart and Vascular Institute, University Hospitals and Case Western Reserve University School of Medicine, Cleveland, OH, USA cSchool of Medicine, University Hospitals Cleveland Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback